Sutro Biopharma, Inc. (STRO)
NGM · Common · CUSIP 869367102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for STRO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
869367102
Market Cap
Small Cap
IPO
9/27/2018 · $15.00/share
Business: Sutro Biopharma, Inc. is a clinical-stage drug discovery, development and manufacturing company creating a braod variety of next-generation protein therapeutics for oncology based on its proprietary, cell-free protein synthesis platform, XpressCF.

Company Contact

CEO
Jane Chung
CFO
Greg Chow
Headquarters
111 Oyster Point Blvd, South San Francisco, CA
Phone
650-881-6500
Fax
650-553-9659
Investor Relations
Emily White · 650-823-7681 · jgraziano@soleburytrout.com
General Email
ewhite@sutrobio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »